Solution for improved delirium management
World's first objective measure of patient brain state
DeltaScan® Brain State Monitor provides a quick and objective measurement of acute encephalopathy (acute brain failure, which encompasses delirium) with high diagnostic performance to support timely interventions
Solution for improved delirium management
World's first objective measure of patient brain state
DeltaScan® Brain State Monitor provides a quick and objective measurement of acute encephalopathy (acute brain failure, which encompasses delirium) with high diagnostic performance to support timely interventions
Acute Brain Failure | Delirium is the Most Common Post-op Complication in Older Adults
Each year, approximately 50% of surgical and ICU patients in the US and Europe are at risk of developing acute brain failure and delirium¹.
In the US the annual health system and societal costs are estimated at $164B, rivaling costs associated with heart disease and diabetes².
“Up to 88% of delirious patients go undetected in daily care practice³”
Marcantonio, 2017, The New England Journal of Medicine
Let’s improve on that
DeltaScan® adds quantitative brain state data to the diagnostic process
Stay up to date with the latest news and upcoming events from Prolira DeltaScan®
Prolira Achievements to Date
Exclusive technology license from University Medical Centre Utrecht
Product Development and 434 patient Multi-Center Study
3 clinical studies completed and enrolling in more
CE certified according to EU MDR since 2020
FDA Clearance
Establishing Clinical & Strategic Partnerships
Interested? Let's get in touch!
Get in touch to learn how you can reshape your acute brain failure | delirium care delivery
sources: ¹ American Geriatric Society ² Inouye et al. 2014 ³ Marcantonio, et al. N Engl J Med 2017
pageversion: 1.0